Pacific Biosciences (PACB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended December 2023, Pacific Biosciences of California (PACB) reported revenue of $58.36 million, up 113.4% over the same period last year. EPS came in at -$0.27, compared to -$0.35 in the year-ago quarter.The reported revenue represents a surprise of +0.20% over the Zacks Consensus Estimate of $58.24 million. With the consensus EPS estimate being -$0.31, the EPS surprise was +12.90%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how t ...